Igbo
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Zhongsheng Tong

Onye ndu ngalaba oncology ara
Dọkịta Osisi
Onye nlekọta edemede masters
Onye otu nọchitere anya na Kọmitii Ọkachamara Ọrịa Kansa Ara nke Òtù Na-alụso Ọrịa Kansa nke China
Onye otu nọọrọ onwe ya na Kọmitii Ọkachamara nke Njikọ Mgbochi Ọrịa Kansa nke China
Osote onyeisi oche nke otu ọkachamara na kansa ara nke Kọmitii Ọrịa Ọrịa Ndị Gara Aga nke Òtù Ndị Agadi nke China
Onyeisi nke Kọmitii Ọkachamara Ọgwụ Kemotherapy nke Tianjin Anti-cancer Association
Onye otu Tianjin Medical Association Oncology Branch
Ọ bụ onye nchịkọta akụkọ nke Chinese Journal of Clinical Oncology, Tianjin Pharmaceutical, Chinese Journal of Breast Disease na Chinese Journal of Comprehensive Clinical Medicine

Okwu Mmalite Ọkachamara:

N'inwe nnukwu ahụmịhe na oncology na ọgwụgwọ ahụike, ọ bụ onye ndu ngalaba ọgwụgwọ ime maka etuto ara, ọkachasị n'ọgwụgwọ zuru oke nke kansa ara. O nwere nnukwu ahụmịhe na neoadjuvant, adjuvant na chemotherapy late-stage maka kansa ara.

13